九典制药获开源证券买入评级，高基数下继续快速增长

金融界08-24

8月24日，九典制药（300705）获开源证券买入评级，近一个月九典制药获得2份研报关注。研究报告称，2024H1公司实现营业收入13.67亿元，同比增长12.19%；归母净利润2.84亿元，同比增长43.77%；扣非归母净利润2.55亿元，同比增长43.24%。2024H1公司毛利率73.14%；净利率为20.80%；销售费用率39.98%；管理费用率2.99%；研发费用率8.35%；经营活动...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2461653457?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-24 22:12","share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","id":"2461653457","market":"sg","top_or_hot":-1,"title":"九典制药获开源证券买入评级，高基数下继续快速增长","media":"金融界","content":"<div>\n<p>8月24日，九典制药（300705）获开源证券买入评级，近一个月九典制药获得2份研报关注。研究报告称，2024H1公司实现营业收入13.67亿元，同比增长12.19%；归母净利润2.84亿元，同比增长43.77%；扣非归母净利润2.55亿元，同比增长43.24%。2024H1公司毛利率73.14%；净利率为20.80%；销售费用率39.98%；管理费用率2.99%；研发费用率8.35%；经营活动...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20240824/c661106499.shtml\">网页链接</a>\n\n</div>\n","source":"tonghuashun","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>九典制药获开源证券买入评级，高基数下继续快速增长</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n九典制药获开源证券买入评级，高基数下继续快速增长\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-24 22:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.10jqka.com.cn/hks/20240824/c661106499.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月24日，九典制药（300705）获开源证券买入评级，近一个月九典制药获得2份研报关注。研究报告称，2024H1公司实现营业收入13.67亿元，同比增长12.19%；归母净利润2.84亿元，同比增长43.77%；扣非归母净利润2.55亿元，同比增长43.24%。2024H1公司毛利率73.14%；净利率为20.80%；销售费用率39.98%；管理费用率2.99%；研发费用率8.35%；经营活动...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20240824/c661106499.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300705","symbol_name":"九典制药","start_time":0,"source_url":"http://stock.10jqka.com.cn/hks/20240824/c661106499.shtml","article_id":"2461653457","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461653457","pubTimestamp":1724508778,"sourceInfo":{"source_id":"tonghuashun","name":"同花顺"},"weMediaInfo":null,"summary":"8月24日，九典制药获开源证券买入评级，近一个月九典制药获得2份研报关注。研究报告称，2024H1公司实现营业收入13.67亿元，同比增长12.19%；归母净利润2.84亿元，同比增长43.77%；扣非归母 ...","collect":0,"end_time":0,"defaultTopTitle":"10jqka.com.cn","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"161027":"证券","300705":"九典制药"},"translate_title":"Jiudian Pharmaceutical received a buy rating from Kaiyuan Securities and continued to grow rapidly under a high base","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"300705":1},"content_text":"8月24日，九典制药（300705）获开源证券买入评级，近一个月九典制药获得2份研报关注。研究报告称，2024H1公司实现营业收入13.67亿元，同比增长12.19%；归母净利润2.84亿元，同比增长43.77%；扣非归母净利润2.55亿元，同比增长43.24%。2024H1公司毛利率73.14%；净利率为20.80%；销售费用率39.98%；管理费用率2.99%；研发费用率8.35%；经营活动产生的现金流量净额4.18亿元。研报认为，公司利润保持高速增长主要系核心品种洛索洛芬钠凝胶贴膏集采后院内销量快速增长及院外市场高速增长；同时，公司收入增速慢于利润增速是因为集采降价、销售改革费用出表及高盈利的院外占比提升等影响。我们看好公司在经皮给药领域的市场优势，预计2024-2026年公司的归母净利润分别为5.10/6.46/8.05亿元。　　风险提示：行业政策变化风险、新药研发风险、原材料供应和价格波动风险等。\n关注同花顺财经（ths518），获取更多机会","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2461653457"}